Companies
Kraig Biocraft Laboratories
OTCQB-listed (KBLB) developer of a transgenic silkworm platform producing "Dragon Silk" recombinant spider-silk fiber; hit 1.3 metric tons/month cocoon output in March 2026 and has publicly targeted defense and industrial biomaterials under an initiative it calls Project Atlas,…
- Country
- United States
- Ticker
- KBLB
OTCQB
Coverage
| CN | EU | US | |
|---|---|---|---|
| fibers-textiles | ✓ | ✓ | ✓ |
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaechanmpaemaepareach
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $10M standby equity purchase agreement (January 2025) | marketscreener.com · stocktitan.net |
| Capacity | 1.8 metric tons of cocoons (as of April 2026), targeting 10 metric tons/month | kblbinvestors.com · kraiglabs.com · stocktitan.net |
| Production site | Lam Dong Province, Vietnam | marketscreener.com |
| Revenue | $0 (pre-revenue as of 2025) | stocktitan.net |
| Regulatory approval | Investment Registration Certificate (IRC) for Vietnam production (January 2025) medium confidence | marketscreener.com |
Independent sources: kblbinvestors.com · kraiglabs.com · marketscreener.com · stocktitan.net
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio-camouflage & bio-armor materials | fibers-textiles | Medium | → |
| Recombinant spider silk & engineered protein fibers | fibers-textiles | Medium | → |
| Silk fibroin (recombinant, biomaterials) | specialty-fine-chem | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.